Laurion Capital Management LP cut its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 36.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,093 shares of the company’s stock after selling 19,194 shares during the period. Laurion Capital Management LP’s holdings in Express Scripts were worth $2,555,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of the business. Twin Capital Management Inc. increased its stake in shares of Express Scripts by 2.1% during the second quarter. Twin Capital Management Inc. now owns 105,510 shares of the company’s stock worth $8,146,000 after buying an additional 2,170 shares during the period. Sustainable Insight Capital Management LLC purchased a new stake in shares of Express Scripts during the second quarter worth approximately $204,000. Baird Financial Group Inc. increased its stake in shares of Express Scripts by 1.8% during the second quarter. Baird Financial Group Inc. now owns 203,174 shares of the company’s stock worth $15,687,000 after buying an additional 3,680 shares during the period. Oregon Public Employees Retirement Fund purchased a new stake in shares of Express Scripts during the second quarter worth approximately $17,669,000. Finally, Columbus Hill Capital Management L.P. purchased a new stake in shares of Express Scripts during the second quarter worth approximately $10,925,000. Institutional investors own 84.73% of the company’s stock.
A number of research firms recently weighed in on ESRX. BidaskClub lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Zacks Investment Research downgraded Express Scripts from a “hold” rating to a “sell” rating in a report on Monday, July 23rd. Royal Bank of Canada upped their price target on Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday, August 27th. William Blair raised Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Finally, Robert W. Baird downgraded Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price target for the company. in a report on Friday, July 20th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $85.58.
Shares of NASDAQ ESRX opened at $90.80 on Monday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. Express Scripts Holding Co has a 1-year low of $55.80 and a 1-year high of $91.03. The firm has a market cap of $51.04 billion, a P/E ratio of 12.79, a P/E/G ratio of 1.14 and a beta of 0.99.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.20 by $0.02. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The firm had revenue of $25.64 billion during the quarter, compared to the consensus estimate of $25.43 billion. During the same period last year, the company earned $1.73 earnings per share. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. sell-side analysts predict that Express Scripts Holding Co will post 9.07 earnings per share for the current fiscal year.
In other Express Scripts news, insider Christine Houston sold 12,898 shares of the stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now owns 110,908 shares in the company, valued at $9,427,180. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.79% of the company’s stock.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More: Understanding Price to Earnings Ratio (PE)
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.